Countries South Korea

Lunit and the JNCCHE Partner in AI Pathology to Advance Precision Oncology

  Lunit (KRX:328130.KQ), a global provider of AI-powered cancer diagnostic solutions, today announced collaboration with the National Cancer Center...

 May 31, 2023 | News

HanAll Biopharma, Daewoong Pharmaceutical, and NurrOn Pharma Collaborate on Parkinson's Therapy

HanAll Biopharma Co., Ltd. (KRX: 009420.KS) and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620.KS) announced that they have entered into a co-developm...

 May 26, 2023 | News

Lunit's AI-Biomarker Platform Shows Predictive Value at ASCO 2023

Lunit (KRX:328130.KQ), a global leader of AI-powered cancer diagnostics and therapeutics solutions, is set to make a significant impact at the American Soc...

 May 26, 2023 | News

Daewoong Pharmaceutical Reveals Bersiporocin's Antifibrotic Mechanism

Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporo...

 May 26, 2023 | News

Avixgen accelerates the progress on new drug pipeline development

DxVx has released development updates on the pipelines of its recently acquired company, Avixgen. DxVx acquired about 63% stake of Avixgen, which is a new ...

 May 25, 2023 | News

PharmAbcine's Novel Antibody Approved for Clinical Trial in nAMD

The Phase I clinical trial is an open-label, multi-center, single and multiple ascending-dose study to assess safety, tolerability, MTD (maximum tolerated ...

 May 24, 2023 | News

SK Bioscience Proposes Vaccine Access Solution at World Economic Forum's Collaborative

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company's CE...

 May 24, 2023 | News

Genome & Company Advances Phase II Trial After Positive Interim Analysis, Proceeds to Second Stage

Genome & Company (CEO: Pae, Jisoo), a global leading microbiome therapeutics developer, announced that this phase II trial (NCT05419362) will continue ...

 May 22, 2023 | News

Gencurix Reports Clinical Results of 15-Year Follow-Up Prognostic Test for Cancer Patients in Korea and Japan

Gencurix announced clinical results of its prognostic test for breast cancer patients at the Global Breast Cancer Conference 2023. The study, 'Long-te...

 May 10, 2023 | News

MEDICAL IP utilizes NVIDIA Omniverse to develop virtual Medical Digital Twins

  MEDIP PRO, a real-time digital twin implementation solution based on medical imaging, is now connected to NVIDIA Omniverse Maximize medical data...

 May 09, 2023 | News

Merck to Establish BioProcessing Production Center in South Korea with Ministry and Daejeon City

  MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem Proposed bioprocessing facility to be based in Daej...

 May 03, 2023 | News

Toshiba's Heavy Ion Therapy System treats patients at Yonsei University Health System.

Toshiba Energy Systems & Solutions Corporation (hereinafter "Toshiba ESS") is pleased to announce today the commencement of treatment using a heavy ion...

 April 30, 2023 | News

Daewoong Pharma partners with Vitalli Bio for new autoimmune drug (DWP213388)

Exclusive rights for the development and commercialization of DWP213388 in the global market to Vitalli Bio, a portfolio company of Aditum Bio, the biotech...

 April 28, 2023 | News

Indica Labs and Lunit Form Strategic Alliance for Integrated Digital Pathology AI Workflows

Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform compa...

 April 27, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in